Another potential obstacle is the nature of the monoclonal antibodies themselves.

Both monoclonal antibodies and their fragments are now of major medical importance.

These kinds of medicines, called monoclonal antibodies, may not work for some people.

Monoclonal antibodies specific to the p24 protein are mixed with the person's blood.

Monoclonal antibodies such as cetuximab may not work for some people.

In some cases, this was because the technology it chose, monoclonal antibodies, wasn't quite ready for prime time.

By contrast, monoclonal antibodies are derived from a single cell line.

He liked the idea that you've had a lot of experience with monoclonal antibodies."

Monoclonal antibodies are made to target and destroy only certain cells in the body.

Hybridomas are used in the industry for the production of monoclonal antibodies.

Several such products are being developed, including monoclonal antibodies.

The use of monoclonal antibodies increases the sensitivity to a large extent.

Both products are monoclonal antibodies, designed to bind to a particular target in the body.

Until 2009, more than 170 monoclonal antibodies received names following this nomenclature.

See the list of monoclonal antibodies for more examples.

The main limitation is the availability of specific monoclonal antibodies required by the model.

This approach is similar to the one taken in the development of bispecific monoclonal antibodies.

Monoclonal antibodies are specific forms of the agents the body usually uses to fight infections.

First, he said, was the expectation that monoclonal antibodies were magic bullets.

Workers have also turned their attention to obtaining all-human monoclonal antibodies.

Cetuximab belongs to a group of drugs known as monoclonal antibodies.

Biological agents, such as monoclonal antibodies that target cancer cells, are also used.

It has designs to become a major producer of insulin and monoclonal antibodies.

Monoclonal antibodies are probably the most specific and promising therapeutic compounds.

Monoclonal antibodies, due to their size, are utilized against cell surface targets.

June - First report of using a monoclonal antibody as a medical test.

Another potential obstacle is the nature of the monoclonal antibodies themselves.

The new drug is a type of compound known as a monoclonal antibody.

It is a type of medication called a monoclonal antibody.

Both monoclonal antibodies and their fragments are now of major medical importance.

The general scheme of a monoclonal antibody development program is described in.

These kinds of medicines, called monoclonal antibodies, may not work for some people.

Monoclonal antibodies specific to the p24 protein are mixed with the person's blood.

Monoclonal antibodies such as cetuximab may not work for some people.

In some cases, this was because the technology it chose, monoclonal antibodies, wasn't quite ready for prime time.

By contrast, monoclonal antibodies are derived from a single cell line.

He liked the idea that you've had a lot of experience with monoclonal antibodies."

Monoclonal antibodies are made to target and destroy only certain cells in the body.

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.

Hybridomas are used in the industry for the production of monoclonal antibodies.

Several such products are being developed, including monoclonal antibodies.

The use of monoclonal antibodies increases the sensitivity to a large extent.

Both products are monoclonal antibodies, designed to bind to a particular target in the body.

"They want me to try to make a monoclonal antibody to a specific protein.

Fulranumab is a human monoclonal antibody designed for the treatment of pain.

Until 2009, more than 170 monoclonal antibodies received names following this nomenclature.

This shows that the drug is a human monoclonal antibody acting against tumors.

Therefore, the drug is a human monoclonal antibody targeting the immune system.

See the list of monoclonal antibodies for more examples.

The main limitation is the availability of specific monoclonal antibodies required by the model.